Carsten Brunn - 28 Jun 2022 Form 4 Insider Report for Surface Oncology, Inc.

Role
Director
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Jun 2022
Net transactions value
$0
Form type
4
Filing time
30 Jun 2022, 20:05:24 UTC
Previous filing
03 Jun 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +48,000 $0.000000 48,000 28 Jun 2022 Common Stock 48,000 $1.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the Options shall vest on June 28, 2023, and the remainder of the Options shall vest in equal monthly installments over the following twelve months, such that all of the Options shall be vested on June 28, 2024, subject to the Reporting Person's continued service relationship with the Company on each such vesting date.